Premier Members Select KARL STORZ CanaryBox ® to be Showcased at Innovation Celebration

The new CanaryBox® from KARL STORZ Endoscopy-America was one of the medical innovations showcased in front of thousands of healthcare providers at Premier’s 2022 Breakthroughs Conference.

CanaryBox was debuted during the conference’s annual Innovation Showcase, an event recognizing advancements in healthcare and highlighting suppliers dedicated to driving innovation and improving patient outcomes.

“KARL STORZ shares Premier’s commitment to providing valuable products to our alliance members that are safe, high-quality, and cost-effective,” said David A. Hargraves, Senior Vice President of Supply Chain, Premier. “These innovations can truly benefit providers in our shared work to transform healthcare and build healthier communities.”

Clinicians and other health system members of Premier selected CanaryBox® for the Innovation Celebration due to its uniqueness, ability to have an impact on unmet clinical needs, and potential to improve patient care. CanaryBox® was one of only eight innovations awarded this distinction!

While some studies suggest there are benefits to music in the operating room, such as reduced stress, increased focus, and perceived calming effects1, 2, 3, 4, there have also been studies that show music can interfere with communication during critical situations4,5,6.

This new operating room integration technology is designed to help clinicians keep the benefits of music while also allowing for the clearest communication during critical patient events in the operating room. If a patient’s vital signs deteriorate, data exported in real-time from a patient monitoring system allows the integrated operating room to dim or even completely mute the music volume automatically.

“Many surgeons appreciate the benefits of music for the operating room environment. The enhanced focus and sense of calm is good for patient care,” says Glenn Jarrett, MD, an orthopedic surgeon. “A system that allows for immediate control of sound in an urgent situation makes perfect sense.”

For more detailed information, including videos about CanaryBox® technology, visit: https://premierinc.com/newsroom/blog or https://www.karlstorz.com/us/en/neo-ip.htm

Premier is a leading healthcare improvement company, uniting an alliance of more than 4,400 U.S. hospitals and health systems and approximately 225,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.


Other industry-related news can be found here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”